[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
David Nierengarten Reiterated (ANAB) at Hold and Held Target at $20 on, Nov 29th, 2023
- 🞛 This publication is a summary or evaluation of another publication
David Nierengarten of Wedbush, Reiterated "AnaptysBio, Inc." (ANAB) at Hold and Held Target at $20 on, Nov 29th, 2023.
David has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $21 on, Thursday, November 2nd, 2023